eli lilly and company mounjaro

News

Eli Lilly sales soar 45% on weight loss drug demand

Eli Lilly Revenue Up on Demand for Mounjaro, Other Weight-Loss Meds

Eli Lilly revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio.

CNBC on MSN · 1d

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.

MarketWatch · 1d

Eli Lilly 1Q Revenue Surges on Demand for Mounjaro, Other Weight-Loss Treatments

Eli Lilly revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio. The drug maker logged net income of $2.76 billion, or $3.06 a share, up from $2.

Eli Lilly slips

The Motley Fool on MSN · 1d

Why Eli Lilly Stock Is Sinking Today

Shares of Eli Lilly ( LLY -10.79%) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The leg down comes as the S&P 500 ( ^GSPC 0.75%) gained 1% and the Nasdaq Composite ( ^IXIC 1.82%) gained 1.9%.

AOL · 1d

Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance

Eli Lilly's weekly prescription data for Zepbound is up 354% year over year while Novo Nordisk's Wegovy is up just 61%. That's based on the latest prescription tracking data by analytics firm IQVIA, which shows total prescriptions for Wegovy at 211,103 in the week of April 18 and Zepbound totaling 338,899 prescriptions in the same week.

Seeking Alpha on MSN · 1d

Eli Lilly slips after lowering earnings outlook

Eli Lilly (LLY) stock dips despite strong weight-loss drug sales as the company's Q1 2025 results fall short of forecasts. Read more here.

1don MSN

Eric Stonestreet Says Mounjaro Was a ‘Game Changer’ for Type 2 Diabetes, Weight Loss: ‘There’s a Pep in My Step' (Exclusive)

Modern Family’ alum Eric Stonestreet opened up to PEOPLE about living with type 2 diabetes and being unable to get a grasp on ...

14hon MSN

'Modern Family' star Eric Stonestreet talks weight loss, Mounjaro and facing stigma

First, he landed his role in "Modern Family," a critically acclaimed ABC sitcom that went on for 11 seasons and catapulted ...

9don MSN

Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...

BioSpace1d

Lilly’s Revenue Leaps 45% Thanks to Zepbound, Mounjaro, Of Course

To say, as CEO David Ricks did, that this was a good quarter, is an understatement. Mounjaro in diabetes brought in $3.84 ...

ConsumerAffairs9d

Eli Lilly sues companies selling compounded versions of Zepbound and Mounjaro

Key takeaways Eli Lilly has filed lawsuits against four telehealth companies—Mochi Health, Fella Health, Willow Health, and ...

Eli Lilly CEO says tariffs are not the answer, urges Trump to move fast on trade deals

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

3don MSN

Jim Cramer on Eli Lilly and Company (LLY): “Riding the wave of GLP-1 success” – Ready to Rebound After a Rare Miss

We recently published a list of Jim Cramer’s Game Plan for This Week: 16 Stocks in Focus. In this article, we are going to ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results